Summit Plc (SMMT)

New Form 8-K - Summit Therapeutics Inc. Filed: 2025-08-11 AccNo: 0001193125-25-178022 Size: 508 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits